A new standard of care
Legal, evidence-based psychedelic treatments
Our focus
Empowering healing
We are developing the infrastructure required for a regulated psychedelics industry.
Clinical care
Ketamine-assisted psychotherapy & other innovative therapies
Retreat network
Legal, medically supervised psychedelic experiences
Research
Clinical research for psychedelic medicines
Our network
Global access to psychedelic medicines
Novamind is growing a network of specialized psychedelic clinics and retreats
Treatment is provided by blending evidence-based principles with psychedelic medicines
We guide individuals through their entire healing journey, both at home and abroad
Our approach
The infrastructure of tomorrow is being built today
Novamind exclusively operates in jurisdictions with established regulations for the use of psychedelics.
We are empowering the people, technology and research that will allow society to safely access psychedelic treatments in guided settings.
Since 2019, Novamind has invested in and acquired world-class psychedelics clinics, retreats and clinical research organizations.
Our healthcare divisions
Our retreat partners
Our retreat partners
Our values
Balancing purpose and profit
Novamind is committed to a values-oriented approach to business. We will use our platform as a force for good, acknowledging and supporting the interests of our stakeholders.
Compassion
Increase access to treatment for marginalized groups
Innovation
Develop and study novel mental health treatment modalities
Stewardship
Responsible management of psychedelics in healthcare
Respect
Collaborate with non-profits, academic and indigenous groups